Rydapt Midostaurin 25 mg

Description

Rydapt is a prescription drug used to treat adults with a cancer of white blood cells known as acute myeloid leukemia (AML). To buy Rydapt 25mg or to know its price contact 3S Corporation.

Manufacturer : Novartis Pharmaceuticals Corporation

Additional Information

Strengths available :  25 mg

Form :  Capsules

Dosage : Usual Adult Dose for Acute Myeloid Leukemia50 mg orally twice a day at approximately 12 hour intervals on Days 8 to 21 of each cycle of induction AND on Days 8 to 21 of each cycle of consolidation.

Usual Adult Dose for Systemic Mastocytosis100 mg orally twice a day at approximately 12 hour intervals. Duration of Therapy: Until disease progression or unacceptable toxicity occurs.

Usual Adult Dose for Leukemia100 mg orally twice a day at approximately 12 hour intervals.Duration of Therapy: Until disease progression or unacceptable toxicity occurs.

Storage : Store at 25°C

Is the medicine FDA  approved : Yes

Date of Approval : April 28, 2017

Side Effects

Common side effects are black, tarry stools, bloody urine, body aches or pain, chest pain, cough, decreased frequency or amount of urine, dizziness, ear congestion, fever or chills, headache, increased thirst, loss of appetite, loss of voice, lower back or side pain, nasal congestion, nausea, painful or difficult urination, pale skin, runny nose, sneezing, sore throat, swelling of the face, fingers, or lower legs, tightness in the chest, troubled breathing, ulcers, sores, or white spots in the mouth, unusual bleeding or bruising, unusual tiredness or weakness, vomiting, weight gain.

PACK SIZE

7 blister cards containing 4 capsules each.

Reviews

There are no reviews yet.

Be the first to review “Rydapt Midostaurin 25 mg”

Your email address will not be published. Required fields are marked *